130 related articles for article (PubMed ID: 3014851)
1. Effect of suloctidil on tomographically quantitated platelet accumulation in Dacron aortic grafts.
Stratton JR; Ritchie JL
Am J Cardiol; 1986 Jul; 58(1):152-6. PubMed ID: 3014851
[TBL] [Abstract][Full Text] [Related]
2. Reduction of indium-111 platelet deposition on Dacron vascular grafts in humans by aspirin plus dipyridamole.
Stratton JR; Ritchie JL
Circulation; 1986 Feb; 73(2):325-30. PubMed ID: 2935327
[TBL] [Abstract][Full Text] [Related]
3. The effect of sulfinpyrazone on platelet deposition on Dacron vascular grafts in man.
Stratton JR; Ritchie JL
Am Heart J; 1985 Mar; 109(3 Pt 1):453-7. PubMed ID: 3156474
[TBL] [Abstract][Full Text] [Related]
4. Failure of ticlopidine to inhibit deposition of indium-111-labeled platelets on Dacron prosthetic surfaces in humans.
Stratton JR; Ritchie JL
Circulation; 1984 Apr; 69(4):677-83. PubMed ID: 6230173
[TBL] [Abstract][Full Text] [Related]
5. Platelet reactivity in human aortic grafts: a prospective, randomized midterm study of platelet adherence and release products in Dacron and polytetrafluoroethylene conduits.
Wakefield TW; Shulkin BL; Fellows EP; Petry NA; Spaulding SA; Stanley JC
J Vasc Surg; 1989 Feb; 9(2):234-43. PubMed ID: 2537433
[TBL] [Abstract][Full Text] [Related]
6. Effect of suloctidil on platelet function in patients with shortened platelet survival time.
Turpie AG; Gent M; deBoer AC; Giroux M; Kinch D; Butt R; Gunstensen J; Saerens E; Genton E
Thromb Res; 1984 Aug; 35(4):397-406. PubMed ID: 6091290
[TBL] [Abstract][Full Text] [Related]
7. Imaging platelet deposition on Dacron bifurcation grafts in man: quantification by a dual-tracer method using 111In-labeled platelets and 99mTc-labeled human serum albumin.
Isaka Y; Kimura K; Etani H; Uehara A; Yoneda S; Kamada T; Kusunoki M; Kim TD; Ohshiro T
Eur J Nucl Med; 1986; 11(10):386-92. PubMed ID: 2938956
[TBL] [Abstract][Full Text] [Related]
8. The effects of new platelet inhibitory drug E-5510 on platelet deposition on aortic bifurcation grafts: assessment by indium-111-oxime labeled platelet imaging.
Suga K; Nishigauchi K; Kume N; Kishimoto K; Matsunaga N; Fujioka K; Zempo N; Kensuke E
Clin Nucl Med; 1998 Jun; 23(6):365-9. PubMed ID: 9619322
[TBL] [Abstract][Full Text] [Related]
9. In vivo quantitation of platelet deposition on human peripheral arterial bypass grafts using indium-111-labeled platelets. Effect of dipyridamole and aspirin.
Pumphrey CW; Chesebro JH; Dewanjee MK; Wahner HW; Hollier LH; Pairolero PC; Fuster V
Am J Cardiol; 1983 Mar; 51(5):796-801. PubMed ID: 6219569
[TBL] [Abstract][Full Text] [Related]
10. Studies of suloctidil in experimental thrombosis in baboons.
Hanson SR; Harker LA
Thromb Haemost; 1985 Jun; 53(3):423-7. PubMed ID: 2996168
[TBL] [Abstract][Full Text] [Related]
11. Natural history of platelet deposition on Dacron aortic bifurcation grafts in the first year after implantation.
Stratton JR; Thiele BL; Ritchie JL
Am J Cardiol; 1983 Aug; 52(3):371-4. PubMed ID: 6223522
[TBL] [Abstract][Full Text] [Related]
12. Indium 111-labeled platelet deposition in woven and knitted Dacron bifurcated aortic grafts with the same patient as a clinical model.
Robicsek F; Duncan GD; Anderson CE; Daugherty HK; Cook JW; Selle JG; Hess PJ; Easton EJ; Burtoft JN
J Vasc Surg; 1987 Jun; 5(6):833-7. PubMed ID: 2953910
[TBL] [Abstract][Full Text] [Related]
13. Platelet deposition on vascular grafts. The accuracy of in vivo quantitation and the significance of in vivo platelet reactivity.
Allen BT; Mathias CJ; Sicard GA; Welch MJ; Clark RE
Ann Surg; 1986 Mar; 203(3):318-28. PubMed ID: 2937375
[TBL] [Abstract][Full Text] [Related]
14. Thromboembolic potential of synthetic vascular grafts in baboons.
Schneider PA; Kotzé HF; Heyns AD; Hanson SR
J Vasc Surg; 1989 Jul; 10(1):75-82. PubMed ID: 2526235
[TBL] [Abstract][Full Text] [Related]
15. Reduction in deposition of indium 111-labeled platelets after autologous endothelial cell seeding of Dacron aortic bifurcation grafts in humans: a preliminary report.
Ortenwall P; Wadenvik H; Kutti J; Risberg B
J Vasc Surg; 1987 Jul; 6(1):17-25. PubMed ID: 2955133
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic activity of Bay u3405, a thromboxane A2-antagonist, in patients with Dacron aortic grafts: a random controlled clinical trial.
Pieters H; Roodt JP; Badenhorst PN; van Wyk V; Schall R; Lötter MG; Hundt HK; Nel CJ
Thromb Haemost; 1993 Dec; 70(6):903-8. PubMed ID: 8165609
[TBL] [Abstract][Full Text] [Related]
17. The effect of indobufen on the thrombogenic potential of a Dacron prosthesis in an artificial circulation.
Sheehan SJ; Monson JR; Salter MC; Rajah DS; Rajah SM; Kester RC
Eur J Vasc Surg; 1988 Aug; 2(4):223-7. PubMed ID: 2975227
[TBL] [Abstract][Full Text] [Related]
18. Double-blind trial of suloctidil versus placebo in moderate to severe mental deterioration.
Baro F; Malfroid M; Waegemans T; Cox JP
Pharmatherapeutica; 1985; 4(6):399-404. PubMed ID: 3001778
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet therapy and vascular grafts. Studies in a baboon ex vivo shunt.
Eldrup-Jorgensen J; Connolly RJ; Mackey WC; Ramberg K; O'Donnell TF; Valeri CR; Callow AD
Arch Surg; 1986 Jul; 121(7):778-81. PubMed ID: 2940991
[TBL] [Abstract][Full Text] [Related]
20. The influence of platelet-graft interaction on platelet survival in patients with aortobifemoral Dacron grafts.
Kotzé HF; Heyns AD; Nel CJ; Roodt JP; Herbst CP; Badenhorst PN; Lötter MG
S Afr Med J; 1992 Jan; 81(1):27-31. PubMed ID: 1530891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
